The addition of ATX inhibitor S32826 or PF8380 abolished the generation of LPA in ovarian cancer stem cells (CSCs) and resulted in the reduction of CSC characteristics, suggesting that ATX regulates the maintenance of ovarian cancer stem cells through an LPA-mediated autocrine mechanism [102]. This evidence concerns the gene ENPP2 and ovarian carcinoma.